
Ernst Geutjes
I am a biotechnology entrepreneur and investment professional with deep expertise in cancer research, oncology drug development and... | Amsterdam, Amsterdam, Netherlands
*50 free lookup(s) per month.
No credit card required.
Ernst Geutjes’s Emails ge****@ag****.com
Ernst Geutjes’s Phone Numbers No phone number available.
Social Media
Ernst Geutjes’s Location Amsterdam, Amsterdam, Netherlands
Ernst Geutjes’s Expertise I am a biotechnology entrepreneur and investment professional with deep expertise in cancer research, oncology drug development and venture creation. I have worked on both sides of the table as an executive in new venture creation and as an investor in oncology start-ups. I am currently the CBO of Flindr Therapeutics. I am a venture partner at Aglaia Oncology Funds, a boutique venture capital firm that is specialized in early-stage oncology therapeutics investments and venture creation and and advisor to oncology biotechs and the oncology venture creator Cumulus Oncology. I am strategically and operationally in all aspects of biotech company formation, but mostly in helping to develop a business plan, R&D strategy, target product profiles, pitch decks and fundraising strategies. I use my solid understanding of market needs, competitive developments and value drivers in the oncology field to help identify killer applications for technology platforms and disease indications for oncology products. My strengths are to simplify complexity at the very early stages of venture creation and develop solid business propositions to enable venture finance investments or dealmaking with pharma. Specialties: oncology, venture capital, company creation, corporate strategy development, operational support LinkedIn Acceptance Policy My network consists of people with whom I have interacted in real-life and from whom I hence have an understanding of their professional capabilities. Accordingly, I only accept people with whom I have already interacted with. Career advice I really like to help individuals with their career developments but I unfortunately get more requests than I can handle. You may find an interview I gave on Cheeky Scientists helpfull: https://www.youtube.com/watch?v=Lfy41wwFJPU If you still have questions where you think I could be of help to you, then I would like to request you to donate money to any charity institution you like, after which I am happy to help you.
Ernst Geutjes’s Current Industry Cumulus Oncology
Ernst
Geutjes’s Prior Industry
Euroclip
|
University Of Amsterdam
|
Academic Medical Center
|
Harvard Medical School
|
Netherlands Cancer Institute
|
Postdoc Career Development Initiative
|
Tno
|
Aglaia Biomedical Ventures
|
Macrophage Pharma
|
Sapreme Technologies
|
Aglaia Oncology Funds
|
Inthera Bioscience
|
Flindr Therapeutics
|
Oncopreneur
|
Genase Therapeutics
|
Vc Life Foundation
|
Cumulus Oncology
Not the Ernst Geutjes you were looking for?
Find accurate emails & phone numbers for over 700M professionals.
Work Experience

Cumulus Oncology
Advisor
Sat Oct 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time) — Present
Vc Life Foundation
Director
Wed Jun 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time) — Present
Aglaia Oncology Funds
Venture Partner
Sun May 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time) — Present
Flindr Therapeutics
Interim Chief Business Officer
Fri Apr 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time) — Present
Oncopreneur
Founder
Fri Apr 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time) — Present
Genase Therapeutics
Vice President Of Business Development
Fri Apr 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time) — Present
Inthera Bioscience
Board Observer
Wed Sep 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time) — Tue Mar 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Sapreme Technologies
Board Observer
Fri Jan 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time) — Tue Mar 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Sapreme Technologies
Non Executive Director
Wed Jan 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time) — Tue Dec 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Aglaia Oncology Funds
Partner
Sun Sep 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time) — Tue Mar 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Sapreme Technologies
Managing Director
Mon Jan 01 2018 00:00:00 GMT+0000 (Coordinated Universal Time) — Sun Dec 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Macrophage Pharma
Board Observer
Wed Feb 01 2017 00:00:00 GMT+0000 (Coordinated Universal Time) — Tue Mar 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Aglaia Biomedical Ventures
Associate
Tue Dec 01 2015 00:00:00 GMT+0000 (Coordinated Universal Time) — Sun Sep 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Aglaia Biomedical Ventures
Business Analyst
Sat Nov 01 2014 00:00:00 GMT+0000 (Coordinated Universal Time) — Tue Dec 01 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Tno
Business developer
Tue May 01 2012 00:00:00 GMT+0000 (Coordinated Universal Time) — Tue Jul 01 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Postdoc Career Development Initiative
Co-organizer PCDI retreat and columnist
Thu Jul 01 2010 00:00:00 GMT+0000 (Coordinated Universal Time) — Thu Sep 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Netherlands Cancer Institute
Ph.D student Cancer Genetics
Sun Jan 01 2006 00:00:00 GMT+0000 (Coordinated Universal Time) — Thu Dec 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Harvard Medical School
Research internship
Thu Jan 01 2004 00:00:00 GMT+0000 (Coordinated Universal Time) — Sat Jan 01 2005 00:00:00 GMT+0000 (Coordinated Universal Time)
University Of Amsterdam
Assistant-teacher Statistics
Wed Jan 01 2003 00:00:00 GMT+0000 (Coordinated Universal Time) — Sat Jan 01 2005 00:00:00 GMT+0000 (Coordinated Universal Time)
Academic Medical Center
research internship
Wed Jan 01 2003 00:00:00 GMT+0000 (Coordinated Universal Time) — Thu Jan 01 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
Euroclip
Media Analist
Tue Jan 01 2002 00:00:00 GMT+0000 (Coordinated Universal Time) — Thu Jan 01 2004 00:00:00 GMT+0000 (Coordinated Universal Time)